IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients - Michael A. Pulsipher; Chris Carlson; Bryan Langholz; Donna A. Wall; Kirk R. Schultz; Nancy Bunin; Ilan R. Kirsch; Julie M. Gastier‐Foster; Michael J. Borowitz; Cindy Desmarais; David Williamson; Michael Kalos; et al. (2015)